ketanserin has been researched along with Thrombophlebitis in 4 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Thrombophlebitis: Inflammation of a vein associated with a blood clot (THROMBUS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two highly sensitive models of arterial and venous thrombosis forming with the test of endothelial stability a complementary system with a maximum stress on the role of vascular lesion were used to test a series of four antithrombotic drugs (heparin, acetylsalicylic acid, dipyridamole, sulfinpyrazone) and four drugs with other indications but with an antithrombotic activity in experiment (prenylamine, troxerutin, ketanserin and pizotifen)." | 3.67 | Antithrombotics in view of thrombosis models. ( Hladovec, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Roose, J | 1 |
| Symoens, J | 1 |
| Pawlak, D | 1 |
| Pawlak, K | 1 |
| Chabielska, E | 1 |
| Małyszko, J | 1 |
| Takada, A | 1 |
| Myśliwiec, M | 1 |
| Buczko, W | 1 |
| Hladovec, J | 2 |
1 trial available for ketanserin and Thrombophlebitis
| Article | Year |
|---|---|
Ketanserin in acute superficial thrombophlebitis.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ketanseri | 1982 |
3 other studies available for ketanserin and Thrombophlebitis
| Article | Year |
|---|---|
A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
Topics: Animals; Aorta, Abdominal; Bleeding Time; Ketanserin; Male; Piperidines; Platelet Aggregation; Rats; | 1998 |
A sensitive model of venous thrombosis in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Female; Heparin; Ketanserin; | 1986 |
Antithrombotics in view of thrombosis models.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Female; Hydroxyethylrutoside; Ketanserin; | 1986 |